We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| DuPont de Nemours Inc | NYSE:DD | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| -0.35 | -0.45% | 78.00 | 79.02 | 78.10 | 78.94 | 1,158,423 | 00:27:01 |
From May 2019 to May 2024
After a more than seven-year study, an independent panel of scientists found a likely link between C-8 exposure and six diseases, including kidney cancer and testicular cancer, allowing plaintiffs with these diseases to file individual claims against DuPont. "Chemical-Discharge Case Against DuPont Goes to Trial" at 8:20 p.m. ET, incorrectly stated that a likely link was found between C-8 exposure and thyroid cancer in the 14th paragraph. (Sept. 15, 2015)
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
(END) Dow Jones Newswires
September 15, 2015 18:42 ET (22:42 GMT)
Copyright (c) 2015 Dow Jones & Company, Inc.
1 Year DuPont de Nemours Chart |
1 Month DuPont de Nemours Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
